Role of NADPH oxidases in liver fibrosis

Antioxidants and Redox Signaling

Volumn 20, Issue 17, 2014, Pages 2854-2872

  Paik, Yong Han ^a,b   Kim, Jonghwa ^a   Aoyama, Tomonori ^c   De Minicis, Samuele ^d   Bataller, Ramon ^e   Brenner, David A ^f  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^e University of North Carolina at Chapel Hill   (United States)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; BILE SALT; LEPTIN; PLATELET DERIVED GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 3; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 5; SMAD PROTEIN; SUPEROXIDE DISMUTASE; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ALCOHOL LIVER DISEASE; CELLULAR DISTRIBUTION; CHRONIC LIVER DISEASE; DOWN REGULATION; FIBROGENESIS; HEPATITIS C; HUMAN; LIVER CELL DAMAGE; LIVER FIBROGENESIS; LIVER FIBROSIS; LIVER INJURY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; ENZYMOLOGY; GENETICS; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; STELLATE CELL;

ANGIOTENSIN II; HEPATIC STELLATE CELLS; HUMANS; LIVER CIRRHOSIS; NADPH OXIDASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84901056473     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5619     Document Type: Review

References (206)

1. Abu Dayyeh BK, Yang M, Dienstag JL, and Chung RT. The effects of angiotensin blocking agents on the progression of liver fibrosis in the HALT-C Trial cohort. Dig Dis Sci 56: 564-568, 2011
2. Adachi T, Togashi H, Suzuki A, Kasai S, Ito J, Sugahara K, and Kawata S. NAD(P)H oxidase plays a crucial role in PDGF-induced proliferation of hepatic stellate cells. Hepatology 41: 1272-1281, 2005
3. Albano E. Alcohol, oxidative stress and free radical damage. Proc Nutr Soc 65: 278-290, 2006
4. Amara N, Goven D, Prost F, Muloway R, Crestani B, and Boczkowski J. NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts. Thorax 65: 733-738, 2010
5. Ambasta RK, Kumar P, Griendling KK, Schmidt HH, Busse R, and Brandes RP. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 279: 45935-45941, 2004
6. Aoyama T, Paik YH, and Seki E. Toll-like receptor signaling and liver fibrosis. Gastroenterol Res Pract 2010, 2010. DOI: 10.1155/2010/192543
7. Aoyama T, Paik YH, Watanabe S, Laleu B, Gaggini F, Fioraso-Cartier L, Molango S, Heitz F, Merlot C, Szyndralewiez C, Page P, and Brenner DA. Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent. Hepatology 56: 2316-2327, 2012
8. Aram G, Potter JJ, Liu X, Wang L, Torbenson MS, and Mezey E. Deficiency of nicotinamide adenine dinucleotide phosphate, reduced form oxidase enhances hepatocellular injury but attenuates fibrosis after chronic carbon tetrachloride administration. Hepatology 49: 911-919, 2009
9. Arteel GE. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 124: 778-790, 2003
10. Asehnoune K, Strassheim D, Mitra S, Kim JY, and Abraham E. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J Immunol 172: 2522-2529, 2004
11. Bae YS, Oh H, Rhee SG, and Yoo YD. Regulation of reactive oxygen species generation in cell signaling. Mol Cells 32: 491-509, 2011
12. Banfi B, Clark RA, Steger K, and Krause KH. Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J Biol Chem 278: 3510-3513, 2003
13. Bataller R and Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis 21: 437-451, 2001
14. Bataller R and Brenner DA. Liver fibrosis. J Clin Invest 115: 209-218, 2005
15. Bataller R, Gines P, Nicolas JM, Gorbig MN, Garcia-Ramallo E, Gasull X, Bosch J, Arroyo V, and Rodes J. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 118: 1149-1156, 2000
16. Bataller R, Paik YH, Lindquist JN, Lemasters JJ, and Brenner DA. Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells. Gastroenterology 126: 529-540, 2004
17. Bataller R, Sancho-Bru P, Gines P, and Brenner DA. Liver fibrogenesis: A new role for the renin-Angiotensin system. Antioxid Redox Signal 7: 1346-1355, 2005
18. Bataller R, Schwabe RF, Choi YH, Yang L, Paik YH, Lindquist J, Qian T, Schoonhoven R, Hagedorn CH, Lemasters JJ, and Brenner DA. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 112: 1383-1394, 2003
19. Becker S, Reinehr R, Grether-Beck S, Eberle A, and Haussinger D. Hydrophobic bile salts trigger ceramide formation through endosomal acidification. Biol Chem 388: 185-196, 2007
20. Beckman JS and Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol 271: C1424-C1437, 1996
21. Bedard K and Krause KH. The NOX family of ROSgenerating NADPH oxidases: Physiology and pathophysiology. Physiol Rev 87: 245-313, 2007
22. Ben Mkaddem S, Pedruzzi E, Werts C, Coant N, Bens M, Cluzeaud F, Goujon JM, Ogier-Denis E, and Vandewalle A. Heat shock protein gp96 and NAD(P)H oxidase 4 play key roles in Toll-like receptor 4-Activated apoptosis during renal ischemia/reperfusion injury. Cell Death Differ 17: 1474-1485, 2010
23. Bondi CD, Manickam N, Lee DY, Block K, Gorin Y, Abboud HE, and Barnes JL. NAD(P)H oxidase mediates TGFbeta1-induced activation of kidney myofibroblasts. J Am Soc Nephrol 21: 93-102, 2010
24. Boudreau HE, Emerson SU, Korzeniowska A, Jendrysik MA, and Leto TL. Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor beta-dependent manner: A new contributor to HCVinduced oxidative stress. J Virol 83: 12934-12946, 2009
25. Bradford BU, Kono H, Isayama F, Kosyk O, Wheeler MD, Akiyama TE, Bleye L, Krausz KW, Gonzalez FJ, Koop DR, and Rusyn I. Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol-induced oxidative DNA damage in rodent liver. Hepatology 41: 336-344, 2005
26. Brenner DA, Kisseleva T, Scholten D, Paik YH, Iwaisako K, Inokuchi S, Schnabl B, Seki E, De Minicis S, Oesterreicher C, and Taura K. Origin of myofibroblasts in liver fibrosis. Fibrogenesis Tissue Repair 5(Suppl 1): S17, 2012
27. Brown DI and Griendling KK. Nox proteins in signal transduction. Free Radic Biol Med 47: 1239-1253, 2009
28. Bubici C, Papa S, Dean K, and Franzoso G.Mutual cross-Talk between reactive oxygen species and nuclear factor-kappa B: Molecular basis and biological significance. Oncogene 25: 6731-6748, 2006
29. Bureau C, Bernad J, Chaouche N, Orfila C, Beraud M, Gonindard C, Alric L, Vinel JP, and Pipy B. Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. J Biol Chem 276: 23077-23083, 2001
30. Cadenas E. Biochemistry of oxygen toxicity. Annu Rev Biochem 58: 79-110, 1989
31. Caja L, Sancho P, Bertran E, Iglesias-Serret D, Gil J, and Fabregat I. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4. Cancer Res 69: 7595-7602, 2009
32. Camma C, Di Bona D, Schepis F, Heathcote EJ, Zeuzem S, Pockros PJ, Marcellin P, Balart L, Alberti A, and Craxi A. Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: A meta-Analysis of individual patient data. Hepatology 39: 333-342, 2004
33. Canbay A, Taimr P, Torok N, Higuchi H, Friedman S, and Gores GJ. Apoptotic body engulfment by a human stellate cell line is profibrogenic. Lab Invest 83: 655-663, 2003
34. Carmona-Cuenca I, Herrera B, Ventura JJ, Roncero C, Fernandez M, and Fabregat I. EGF blocks NADPH oxidase activation by TGF-beta in fetal rat hepatocytes, impairing oxidative stress, and cell death. J Cell Physiol 207: 322-330, 2006
35. Carmona-Cuenca I, Roncero C, Sancho P, Caja L, Fausto N, Fernandez M, and Fabregat I. Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-Apoptotic activity. J Hepatol 49: 965-976, 2008
36. Carter BJ, Anklesaria P, Choi S, and Engelhardt JF. Redox modifier genes and pathways in amyotrophic lateral sclerosis. Antioxid Redox Signal 11: 1569-1586, 2009
37. Cevik MO, Katsuyama M, Kanda S, Kaneko T, Iwata K, Ibi M, Matsuno K, Kakehi T, Cui W, Sasaki M, and Yabe-Nishimura C. The AP-1 site is essential for the promoter activity of NOX1/NADPH oxidase, a vascular superoxideproducing enzyme: Possible involvement of the ERK1/2-JunB pathway. Biochem Biophys Res Commun 374: 351-355, 2008
38. Chang TT, Liaw YF, Wu SS, Schiff E, Han KH, Lai CL, Safadi R, Lee SS, Halota W, Goodman Z, Chi YC, Zhang H, Hindes R, Iloeje U, Beebe S, and Kreter B. Long-Term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology 52: 886-893, 2010
39. Chen F, Haigh S, Barman S, and Fulton DJ. From form to function: The role of Nox4 in the cardiovascular system. Front Physiol 3: 412, 2012
40. Chen K, Craige SE, and Keaney JF Jr. Downstream targets and intracellular compartmentalization in Nox signaling. Antioxid Redox Signal 11: 2467-2480, 2009
41. Chen K, Kirber MT, Xiao H, Yang Y, and Keaney JF Jr. Regulation of ROS signal transduction by NADPH oxidase 4 localization. J Cell Biol 181: 1129-1139, 2008
42. Cheng G, Cao Z, Xu X, van Meir EG, and Lambeth JD. Homologs of gp91phox: Cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269: 131-140, 2001
43. Choi J and Ou JH. Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol Gastrointest Liver Physiol 290: G847-G851, 2006
44. Choi SS, Sicklick JK, Ma Q, Yang L, Huang J, Qi Y, Chen W, Li YX, Goldschmidt-Clermont PJ, and Diehl AM. Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice. Hepatology 44: 1267-1277, 2006
45. Cholongitas E, Vibhakorn S, Lodato F, and Burroughs AK. Angiotensin II antagonists in patients with recurrent hepatitis C virus infection after liver transplantation. Liver Int 30: 334-335, 2010
46. Cifuentes-Pagano E, Csanyi G, and Pagano PJ. NADPH oxidase inhibitors: A decade of discovery from Nox2ds to HTS. Cell Mol Life Sci 69: 2315-2325, 2012
47. Clempus RE, Sorescu D, Dikalova AE, Pounkova L, Jo P, Sorescu GP, Schmidt HH, Lassegue B, and Griendling KK. Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 27: 42-48, 2007
48. Colmenero J, Bataller R, Sancho-Bru P, Bellot P, Miquel R, Moreno M, Jares P, Bosch J, Arroyo V, Caballeria J, and Gines P. Hepatic expression of candidate genes in patients with alcoholic hepatitis: Correlation with disease severity. Gastroenterology 132: 687-697, 2007
49. Colmenero J, Bataller R, Sancho-Bru P, Dominguez M, Moreno M, Forns X, Bruguera M, Arroyo V, Brenner DA, and Gines P. Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C. Am J Physiol Gastrointest Liver Physiol 297: G726-G734, 2009
50. Cong M, Iwaisako K, Jiang C, and Kisseleva T. Cell signals influencing hepatic fibrosis. Int J Hepatol 2012: 158547, 2012
51. Corey KE, Shah N, Misdraji J, Abu Dayyeh BK, Zheng H, Bhan AK, and Chung RT. The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C. Liver Int 29: 748-753, 2009
52. Croquet V, Moal F, Veal N, Wang J, Oberti F, Roux J, Vuillemin E, Gallois Y, Douay O, Chappard D, and Cales P. Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension. J Hepatol 37: 773-780, 2002
53. Cucoranu I, Clempus R, Dikalova A, Phelan PJ, Ariyan S, Dikalov S, and Sorescu D. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 97: 900-907, 2005
54. Cui W, Matsuno K, Iwata K, Ibi M, Matsumoto M, Zhang J, Zhu K, Katsuyama M, Torok NJ, and Yabe-Nishimura C. NOX1/nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) oxidase promotes proliferation of stellate cells and aggravates liver fibrosis induced by bile duct ligation. Hepatology 54: 949-958, 2011
55. Czaja MJ. Cell signaling in oxidative stress-induced liver injury. Semin Liver Dis 27: 378-389, 2007
56. De Bleser PJ, Xu G, Rombouts K, Rogiers V, and Geerts A. Glutathione levels discriminate between oxidative stress and transforming growth factor-beta signaling in activated rat hepatic stellate cells. J Biol Chem 274: 33881-33887, 1999
57. De Minicis S, Bataller R, and Brenner DA. NADPH oxidase in the liver: Defensive, offensive, or fibrogenic?. Gastroenterology 131: 272-275, 2006
58. De Minicis S, Seki E, Oesterreicher C, Schnabl B, Schwabe RF, and Brenner DA. Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells. Hepatology 48: 2016-2026, 2008
59. De Minicis S, Seki E, Paik YH, Osterreicher CH, Kodama Y, Kluwe J, Torozzi L, Miyai K, Benedetti A, Schwabe RF, and Brenner DA. Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis. Hepatology 52: 1420-1430, 2010
60. De Mochel NS, Seronello S, Wang SH, Ito C, Zheng JX, Liang TJ, Lambeth JD, and Choi J. Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection. Hepatology 52: 47-59, 2010
61. DeLeo FR, Burritt JB, Yu L, Jesaitis AJ, Dinauer MC, and Nauseef WM. Processing and maturation of flavocytochrome b558 include incorporation of heme as a prerequisite for heterodimer assembly. J Biol Chem 275: 13986-13993, 2000
62. Desmouliere A, Darby IA, and Gabbiani G. Normal and pathologic soft tissue remodeling: Role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab Invest 83: 1689-1707, 2003
63. Diebold I, Djordjevic T, Petry A, Hatzelmann A, Tenor H, Hess J, and Gorlach A. Phosphodiesterase 2 mediates redox-sensitive endothelial cell proliferation and angiogenesis by thrombin via Rac1 and NADPH oxidase 2. Circ Res 104: 1169-1177, 2009
64. Djamali A, Vidyasagar A, Adulla M, Hullett D, and Reese S. Nox-2 is a modulator of fibrogenesis in kidney allografts. Am J Transplant 9: 74-82, 2009
65. Drummond GR, Selemidis S, Griendling KK, and Sobey CG. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 10: 453-471, 2011
66. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142: 1264-1273.e1261, 2012
67. Fan CY, Katsuyama M, and Yabe-Nishimura C. PKCdelta mediates up-regulation of NOX1, a catalytic subunit of NADPH oxidase, via transactivation of the EGF receptor: Possible involvement of PKCdelta in vascular hypertrophy. Biochem J 390: 761-767, 2005
68. Frey RS, Ushio-Fukai M, and Malik AB. NADPH oxidasedependent signaling in endothelial cells: Role in physiology and pathophysiology. Antioxid Redox Signal 11: 791-810, 2009
69. Fridovich I. Superoxide radical: An endogenous toxicant. Annu Rev Pharmacol Toxicol 23: 239-257, 1983
70. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 134: 1655-1669, 2008
71. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275: 2247-2250, 2000
72. Friedman SL, Roll FJ, Boyles J, and Bissell DM. Hepatic lipocytes: The principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci USA 82: 8681-8685, 1985
73. Gao XP, Standiford TJ, Rahman A, Newstead M, Holland SM, Dinauer MC, Liu QH, and Malik AB. Role of NADPH oxidase in the mechanism of lung neutrophil sequestration and microvessel injury induced by Gram-negative sepsis: Studies in p47phox-/-And gp91phox-/-mice. J Immunol 168: 3974-3982, 2002
74. Garcia-Mediavilla MV, Sanchez-Campos S, Gonzalez-Perez P, Gomez-Gonzalo M, Majano PL, Lopez-Cabrera M, Clemente G, Garcia-Monzon C, and Gonzalez-Gallego J. Differential contribution of hepatitis C virus NS5A and core proteins to the induction of oxidative and nitrosative stress in human hepatocyte-derived cells. J Hepatol 43: 606-613, 2005
75. Garrido AM and Griendling KK. NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol 302: 148-158, 2009
76. Geiszt M, Kopp JB, Varnai P, and Leto TL. Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA 97: 8010-8014, 2000
77. Goyal P, Weissmann N, Rose F, Grimminger F, Schafers HJ, Seeger W, and Hanze J. Identification of novel Nox4 splice variants with impact on ROS levels in A549 cells. Biochem Biophys Res Commun 329: 32-39, 2005
78. Graham KA, Kulawiec M, Owens KM, Li X, Desouki MM, Chandra D, and Singh KK. NADPH oxidase 4 is an oncoprotein localized to mitochondria. Cancer Biol Ther 10: 223-231, 2010
79. Green DE, Murphy TC, Kang BY, Kleinhenz JM, Szyndralewiez C, Page P, Sutliff RL, and Hart CM. The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation. Am J Respir Cell Mol Biol 47: 718-726, 2012
80. Griendling KK and Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 91: 21-27, 2000
81. Guimaraes EL, Empsen C, Geerts A, and van Grunsven LA. Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells. J Hepatol 52: 389-397, 2010
82. Guo J, Loke J, Zheng F, Hong F, Yea S, Fukata M, Tarocchi M, Abar OT, Huang H, Sninsky JJ, and Friedman SL. Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses. Hepatology 49: 960-968, 2009
83. Hammel P, Couvelard A, O'Toole D, Ratouis A, Sauvanet A, Flejou JF, Degott C, Belghiti J, Bernades P, Valla D, Ruszniewski P, and Levy P. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 344: 418-423, 2001
84. Hardie WD, Glasser SW, and Hagood JS. Emerging concepts in the pathogenesis of lung fibrosis. Am J Pathol 175: 3-16, 2009
85. Harraz MM, Marden JJ, Zhou W, Zhang Y, Williams A, Sharov VS, Nelson K, Luo M, Paulson H, Schoneich C, and Engelhardt JF. SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J Clin Invest 118: 659-670, 2008
86. Hecker L, Cheng J, and Thannickal VJ. Targeting NOX enzymes in pulmonary fibrosis. Cell Mol Life Sci 69: 2365-2371, 2012
87. Hecker L, Vittal R, Jones T, Jagirdar R, Luckhardt TR, Horowitz JC, Pennathur S, Martinez FJ, and Thannickal VJ. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med 15: 1077-1081, 2009
88. Hellerbrand C, Stefanovic B, Giordano F, Burchardt ER, and Brenner DA. The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo. J Hepatol 30: 77-87, 1999
89. Helmcke I, Heumuller S, Tikkanen R, Schroder K, and Brandes RP. Identification of structural elements in Nox1 and Nox4 controlling localization and activity. Antioxid Redox Signal 11: 1279-1287, 2009
90. Herrera B, Fernandez M, Alvarez AM, Roncero C, Benito M, Gil J, and Fabregat I. Activation of caspases occurs downstream from radical oxygen species production, BclxL down-regulation, and early cytochrome C release in apoptosis induced by transforming growth factor beta in rat fetal hepatocytes. Hepatology 34: 548-556, 2001
91. Heymes C, Bendall JK, Ratajczak P, Cave AC, Samuel JL, Hasenfuss G, and Shah AM. Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 41: 2164-2171, 2003
92. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, and Griendling KK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24: 677-683, 2004
93. Hu R, Wang YL, Edderkaoui M, Lugea A, Apte MV, and Pandol SJ. Ethanol augments PDGF-induced NADPH oxidase activity and proliferation in rat pancreatic stellate cells. Pancreatology 7: 332-340, 2007
94. Ikeda S, Yamaoka-Tojo M, Hilenski L, Patrushev NA, Anwar GM, Quinn MT, and Ushio-Fukai M. IQGAP1 regulates reactive oxygen species-dependent endothelial cell migration through interacting with Nox2. Arterioscler Thromb Vasc Biol 25: 2295-2300, 2005
95. Inagami T. The renin-Angiotensin system. Essays Biochem 28: 147-164, 1994
96. Jaquet V, Scapozza L, Clark RA, Krause KH, and Lambeth JD. Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets. Antioxid Redox Signal 11: 2535-2552, 2009
97. Jiang JX, Chen X, Serizawa N, Szyndralewiez C, Page P, Schroder K, Brandes RP, Devaraj S, and Torok NJ. Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo. Free Radic Biol Med 53: 289-296, 2012
98. Jiang JX, Venugopal S, Serizawa N, Chen X, Scott F, Li Y, Adamson R, Devaraj S, Shah V, Gershwin ME, Friedman SL, and Torok NJ. Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo. Gastroenterology 139: 1375-1384, 2010
99. Jones SA, O'Donnell VB, Wood JD, Broughton JP, Hughes EJ, and Jones OT. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol 271: H1626-H1634, 1996
100. Kanno K, Tazuma S, and Chayama K. AT1A-deficient mice show less severe progression of liver fibrosis induced by CCl(4). Biochem Biophys Res Commun 308: 177-183, 2003
101. Kaplan DE, Sugimoto K, Newton K, Valiga ME, Ikeda F, Aytaman A, Nunes FA, Lucey MR, Vance BA, Vonderheide RH, Reddy KR, McKeating JA, and Chang KM. Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C. Gastroenterology 132: 654-666, 2007
102. Katsuyama M, Fan C, Arakawa N, Nishinaka T, Miyagishi M, Taira K, and Yabe-Nishimura C. Essential role of ATF-1 in induction of NOX1, a catalytic subunit of NADPH oxidase: Involvement of mitochondrial respiratory chain. Biochem J 386: 255-261, 2005
103. Kim JH, Song SY, Park SG, Song SU, Xia Y, and Sung JH. Primary involvement of NADPH oxidase 4 in hypoxiainduced generation of reactive oxygen species in adiposederived stem cells. Stem Cells Dev 21: 2212-2221, 2012
104. Kim JS, Yeo S, Shin DG, Bae YS, Lee JJ, Chin BR, Lee CH, and Baek SH. Glycogen synthase kinase 3beta and betacatenin pathway is involved in toll-like receptor 4-mediated NADPH oxidase 1 expression in macrophages. FEBS J 277: 2830-2837, 2010
105. Kim MY, Cho MY, Baik SK, Jeong PH, Suk KT, Jang YO, Yea CJ, Kim JW, Kim HS, Kwon SO, Yoo BS, Kim JY, Eom MS, Cha SH, and Chang SJ. Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis-A randomized open-label controlled study. Liver Int 32: 977-987, 2012
106. Kisseleva T, Uchinami H, Feirt N, Quintana-Bustamante O, Segovia JC, Schwabe RF, and Brenner DA. Bone marrowderived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 45: 429-438, 2006
107. Kono H, Bradford BU, Yin M, Sulik KK, Koop DR, Peters JM, Gonzalez FJ, McDonald T, Dikalova A, Kadiiska MB, Mason RP, and Thurman RG. CYP2E1 is not involved in early alcohol-induced liver injury. Am J Physiol 277: G1259-G1267, 1999
108. Kono H, Rusyn I, Uesugi T, Yamashina S, Connor HD, Dikalova A, Mason RP, and Thurman RG. Diphenyleneiodonium sulfate, an NADPH oxidase inhibitor, prevents early alcohol-induced liver injury in the rat. Am J Physiol Gastrointest Liver Physiol 280: G1005-G1012, 2001
109. Kono H, Rusyn I, Yin M, Gabele E, Yamashina S, Dikalova A, Kadiiska MB, Connor HD, Mason RP, Segal BH, Bradford BU, Holland SM, and Thurman RG. NADPH oxidasederived free radicals are key oxidants in alcohol-induced liver disease. J Clin Invest 106: 867-872, 2000
110. Kuwahara F, Kai H, Tokuda K, Kai M, Takeshita A, Egashira K, and Imaizumi T. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 106: 130-135, 2002
111. Kweon YO, Goodman ZD, Dienstag JL, Schiff ER, Brown NA, Burchardt E, Schoonhoven R, Brenner DA, and Fried MW. Decreasing fibrogenesis: An immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J Hepatol 35: 749-755, 2001
112. Laleu B, Gaggini F, Orchard M, Fioraso-Cartier L, Cagnon L, Houngninou-Molango S, Gradia A, Duboux G, Merlot C, Heitz F, Szyndralewiez C, and Page P. First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis. J Med Chem 53: 7715-7730, 2010
113. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4: 181-189, 2004
114. Landmesser U, Cai H, Dikalov S, McCann L, Hwang J, Jo H, Holland SM, and Harrison DG. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40: 511-515, 2002
115. Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, and Griendling KK. Novel gp91(phox) homologues in vascular smooth muscle cells: Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88: 888-894, 2001
116. Latella G, Vetuschi A, Sferra R, Catitti V, D'Angelo A, Zanninelli G, Flanders KC, and Gaudio E. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice. Liver Int 29: 997-1009, 2009
117. Lee KS, Buck M, Houglum K, and Chojkier M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 96: 2461-2468, 1995
118. Lerat H, Honda M, Beard MR, Loesch K, Sun J, Yang Y, Okuda M, Gosert R, Xiao SY, Weinman SA, and Lemon SM. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 122: 352-365, 2002
119. Li Q, Harraz MM, Zhou W, Zhang LN, Ding W, Zhang Y, Eggleston T, Yeaman C, Banfi B, and Engelhardt JF. Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes. Mol Cell Biol 26: 140-154, 2006
120. Li Q, Zhang Y, Marden JJ, Banfi B, and Engelhardt JF. Endosomal NADPH oxidase regulates c-Src activation following hypoxia/reoxygenation injury. Biochem J 411: 531-541, 2008
121. Lieber CS, Weiss DG, Groszmann R, Paronetto F, and Schenker S. II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease. Alcohol Clin Exp Res 27: 1765-1772, 2003
122. Lindor KD, Kowdley KV, Heathcote EJ, Harrison ME, Jorgensen R, Angulo P, Lymp JF, Burgart L, and Colin P. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial. Hepatology 39: 770-778, 2004
123. Lyle AN, Deshpande NN, Taniyama Y, Seidel-Rogol B, Pounkova L, Du P, Papaharalambus C, Lassegue B, and Griendling KK. Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res 105: 249-259, 2009
124. Maher JJ, Tzagarakis C, and Gimenez A. Malondialdehyde stimulates collagen production by hepatic lipocytes only upon activation in primary culture. Alcohol Alcohol 29: 605-610, 1994
125. Maraldi T, Prata C, Caliceti C, Vieceli Dalla Sega F, Zambonin L, Fiorentini D, and Hakim G. VEGF-induced ROS generation from NAD(P)H oxidases protects human leukemic cells from apoptosis. Int J Oncol 36: 1581-1589, 2010
126. Marcellin P, Gane E, Buti M, Afdhal N, Sievert W, Jacobson IM, Washington MK, Germanidis G, Flaherty JF, Schall RA, Bornstein JD, Kitrinos KM, Subramanian GM, McHutchison JG, and Heathcote EJ. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: A 5-year open-label follow-up study. Lancet 381: 468-475, 2013
127. Martinon F, Chen X, Lee AH, and Glimcher LH. TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nat Immunol 11: 411-418, 2010
128. Martyn KD, Frederick LM, von Loehneysen K, Dinauer MC, and Knaus UG. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal 18: 69-82, 2006
129. Miana-Mena FJ, Gonzalez-Mingot C, Larrode P, Munoz MJ, Olivan S, Fuentes-Broto L, Martinez-Ballarin E, Reiter RJ, Osta R, and Garcia JJ. Monitoring systemic oxidative stress in an animal model of amyotrophic lateral sclerosis. J Neurol 258: 762-769, 2011
130. Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, and Guallar E. Meta-Analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142: 37-46, 2005
131. Miller FJ Jr., Filali M, Huss GJ, Stanic B, Chamseddine A, Barna TJ, and Lamb FS. Cytokine activation of nuclear factor kappa B in vascular smooth muscle cells requires signaling endosomes containing Nox1 and ClC-3. Circ Res 101: 663-671, 2007
132. Miyoshi H, Rust C, Roberts PJ, Burgart LJ, and Gores GJ. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology 117: 669-677, 1999
133. Moldovan L, Moldovan NI, Sohn RH, Parikh SA, and Goldschmidt-Clermont PJ. Redox changes of cultured endothelial cells and actin dynamics. Circ Res 86: 549-557, 2000
134. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K, and Munzel T. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90: E58-E65, 2002
135. Nauseef WM. Biological roles for the NOX family NADPH oxidases. J Biol Chem 283: 16961-16965, 2008
136. Nieto N, Greenwel P, Friedman SL, Zhang F, Dannenberg AJ, and Cederbaum AI. Ethanol and arachidonic acid increase alpha 2(I) collagen expression in rat hepatic stellate cells overexpressing cytochrome P450 2E1. Role of H2O2 and cyclooxygenase-2. J Biol Chem 275: 20136-20145, 2000
137. Novo E, Marra F, Zamara E, Valfre di Bonzo L, Caligiuri A, Cannito S, Antonaci C, Colombatto S, Pinzani M, and Parola M. Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells. Gut 55: 90-97, 2006
138. Oakley FD, Abbott D, Li Q, and Engelhardt JF. Signaling components of redox active endosomes: The redoxosomes. Antioxid Redox Signal 11: 1313-1333, 2009
139. Oakley FD, Smith RL, and Engelhardt JF. Lipid rafts and caveolin-1 coordinate interleukin-1beta (IL-1beta)-dependent activation of NFkappaB by controlling endocytosis of Nox2 and IL-1beta receptor 1 from the plasma membrane. J Biol Chem 284: 33255-33264, 2009
140. Oberhammer FA, Pavelka M, Sharma S, Tiefenbacher R, Purchio AF, Bursch W, and Schulte-Hermann R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc Natl Acad Sci USA 89: 5408-5412, 1992
141. Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, and Weinman SA. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122: 366-375, 2002
142. Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, Massague J, and Niehrs C. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature 401: 480-485, 1999
143. Paik YH, Iwaisako K, Seki E, Inokuchi S, Schnabl B, Osterreicher CH, Kisseleva T, and Brenner DA. The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in mice. Hepatology 53: 1730-1741, 2011
144. Paik YH, Lee KS, Lee HJ, Yang KM, Lee SJ, Lee DK, Han KH, Chon CY, Lee SI, Moon YM, and Brenner DA. Hepatic stellate cells primed with cytokines upregulate inflammation in response to peptidoglycan or lipoteichoic acid. Lab Invest 86: 676-686, 2006
145. Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, and Brenner DA. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 37: 1043-1055, 2003
146. Paizis G, Cooper ME, Schembri JM, Tikellis C, Burrell LM, and Angus PW. Up-regulation of components of the reninangiotensin system in the bile duct-ligated rat liver. Gastroenterology 123: 1667-1676, 2002
147. Paizis G, Gilbert RE, Cooper ME, Murthi P, Schembri JM, Wu LL, Rumble JR, Kelly DJ, Tikellis C, Cox A, Smallwood RA, and Angus PW. Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis. J Hepatol 35: 376-385, 2001
148. Park HS, Chun JN, Jung HY, Choi C, and Bae YS. Role of NADPH oxidase 4 in lipopolysaccharide-induced proinflammatory responses by human aortic endothelial cells. Cardiovasc Res 72: 447-455, 2006
149. Park HS, Jung HY, Park EY, Kim J, Lee WJ, and Bae YS. Cutting edge: Direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J Immunol 173: 3589-3593, 2004
150. Parola M and Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol 35: 297-306, 2001
151. Pendergrass KD, Gwathmey TM, Michalek RD, Grayson JM, and Chappell MC. The angiotensin II-AT1 receptor stimulates reactive oxygen species within the cell nucleus. Biochem Biophys Res Commun 384: 149-154, 2009
152. Petry A, Weitnauer M, and Gorlach A. Receptor activation of NADPH oxidases. Antioxid Redox Signal 13: 467-487, 2010
153. Pinzani M, Gesualdo L, Sabbah GM, and Abboud HE. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 84: 1786-1793, 1989
154. Poli G and Parola M. Oxidative damage and fibrogenesis. Free Radic Biol Med 22: 287-305, 1997
155. Ramadori G and Saile B. Portal tract fibrogenesis in the liver. Lab Invest 84: 153-159, 2004
156. Ramjaun AR, Tomlinson S, Eddaoudi A, and Downward J. Upregulation of two BH3-only proteins, Bmf and Bim, during TGF beta-induced apoptosis. Oncogene 26: 970-981, 2007
157. Reinehr R, Becker S, Eberle A, Grether-Beck S, and Haussinger D. Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J Biol Chem 280: 27179-27194, 2005
158. Reinehr R, Becker S, Keitel V, Eberle A, Grether-Beck S, and Haussinger D. Bile salt-induced apoptosis involves NADPH oxidase isoform activation. Gastroenterology 129: 2009-2031, 2005
159. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol 3: 1129-1134, 2002
160. Rimola A, Londono MC, Guevara G, Bruguera M, Navasa M, Forns X, Garcia-Retortillo M, Garcia-Valdecasas JC, and Rodes J. Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation. Transplantation 78: 686-691, 2004
161. Rockey DC, Boyles JK, Gabbiani G, and Friedman SL. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol 24: 193-203, 1992
162. Rotrosen D, Yeung CL, Leto TL, Malech HL, and Kwong CH. Cytochrome b558: The flavin-binding component of the phagocyte NADPH oxidase. Science 256: 1459-1462, 1992
163. Sancho P, Mainez J, Crosas-Molist E, Roncero C, Fernandez-Rodriguez CM, Pinedo F, Huber H, Eferl R, Mikulits W, and Fabregat I. NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development. PLoS One 7: E45285, 2012
164. Santos CXC, Nabeebaccus AA, Shah AM, Camargo LL, Filho SV, and Lopes LR. Endoplasmic reticulum stress and Nox-mediated reactive oxygen species signaling in the peripheral vasculature: Potential role in hypertension. Antioxid Redox Signal. 20: 121-134, 2014
165. Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, Neuschwander-Tetri BA, Lavine JE, Tonascia J, Unalp A, Van Natta M, Clark J, Brunt EM, Kleiner DE, Hoofnagle JH, and Robuck PR. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 362: 1675-1685, 2010
166. Schnabl B, Kweon YO, Frederick JP, Wang XF, Rippe RA, and Brenner DA. The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology 34: 89-100, 2001
167. Scholten D, Reichart D, Paik YH, Lindert J, Bhattacharya J, Glass CK, Brenner DA, and Kisseleva T. Migration of fibrocytes in fibrogenic liver injury. Am J Pathol 179: 189-198, 2011
168. Schroder K, Zhang M, Benkhoff S, Mieth A, Pliquett R, Kosowski J, Kruse C, Luedike P, Michaelis UR, Weissmann N, Dimmeler S, Shah AM, and Brandes RP. Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res 110: 1217-1225, 2012
169. Sedeek M, Callera G, Montezano A, Gutsol A, Heitz F, Szyndralewiez C, Page P, Kennedy CR, Burns KD, Touyz RM, and Hebert RL. Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: Implications in type 2 diabetic nephropathy. Am J Physiol Renal Physiol 299: F1348-F1358, 2010
170. Segal BH, Leto TL, Gallin JI, Malech HL, and Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 79: 170-200, 2000
171. Seki E and Brenner DA. Toll-like receptors and adaptor molecules in liver disease: Update. Hepatology 48: 322-335, 2008
172. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, and Schwabe RF. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13: 1324-1332, 2007
173. Serrander L, Cartier L, Bedard K, Banfi B, Lardy B, Plastre O, Sienkiewicz A, Forro L, Schlegel W, and Krause KH. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J 406: 105-114, 2007
174. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, and Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity: Upstream mediators. Circ Res 91: 406-413, 2002
175. Sheppard D. Transforming growth factor beta: A central modulator of pulmonary and airway inflammation and fibrosis. Proc Am Thorac Soc 3: 413-417, 2006
176. Sodeman T, Bronk SF, Roberts PJ, Miyoshi H, and Gores GJ. Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. Am J Physiol Gastrointest Liver Physiol 278: G992-G999, 2000
177. Sommerfeld A, Reinehr R, and Haussinger D. Bile acidinduced epidermal growth factor receptor activation in quiescent rat hepatic stellate cells can trigger both proliferation and apoptosis. J Biol Chem 284: 22173-22183, 2009
178. Sookoian S, Fernandez MA, and Castano G. Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: A pilot study. World J Gastroenterol 11: 7560-7563, 2005
179. Sturrock A, Cahill B, Norman K, Huecksteadt TP, Hill K, Sanders K, Karwande SV, Stringham JC, Bull DA, Gleich M, Kennedy TP, and Hoidal JR. Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 290: L661-L673, 2006
180. Svegliati-Baroni G, Ridolfi F, Hannivoort R, Saccomanno S, Homan M, De Minicis S, Jansen PL, Candelaresi C, Benedetti A, and Moshage H. Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor. Gastroenterology 128: 1042-1055, 2005
181. Terui Y, Saito T, Watanabe H, Togashi H, Kawata S, Kamada Y, and Sakuta S. Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C. Hepatology 36: 1022, 2002
182. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, and Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194: 1395-1406, 2001
183. Thoren F, Romero A, Lindh M, Dahlgren C, and Hellstrand K. A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: Role of NADPH oxidase-derived oxygen radicals. J Leukoc Biol 76: 1180-1186, 2004
184. Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, Pagano PJ, and Schiffrin EL. Expression of a functionally active gp91phox-containing neutrophil-Type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: Regulation by angiotensin II. Circ Res 90: 1205-1213, 2002
185. Ueberham E, Low R, Ueberham U, Schonig K, Bujard H, and Gebhardt R. Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis. Hepatology 37: 1067-1078, 2003
186. Ushio-Fukai M. Compartmentalization of redox signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal 11: 1289-1299, 2009
187. Ushio-Fukai M. Redox signaling in angiogenesis: Role of NADPH oxidase. Cardiovasc Res 71: 226-235, 2006
188. von Lohneysen K, Noack D, Jesaitis AJ, Dinauer MC, and Knaus UG. Mutational analysis reveals distinct features of the Nox4-p22 phox complex. J Biol Chem 283: 35273-35282, 2008
189. von Lohneysen K, Noack D, Wood MR, Friedman JS, and Knaus UG. Structural insights into Nox4 and Nox2: Motifs involved in function and cellular localization. Mol Cell Biol 30: 961-975, 2010
190. Wang B, Trippler M, Pei R, Lu M, Broering R, Gerken G, and Schlaak JF. Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication. J Hepatol 51: 1037-1045, 2009
191. Wei HS, Li DG, Lu HM, Zhan YT, Wang ZR, Huang X, Zhang J, Cheng JL, and Xu QF. Effects of AT1 receptor antagonist, losartan, on rat hepatic fibrosis induced by CCl(4). World J Gastroenterol 6: 540-545, 2000
192. Wheeler MD, Kono H, Yin M, Nakagami M, Uesugi T, Arteel GE, Gabele E, Rusyn I, Yamashina S, Froh M, Adachi Y, Iimuro Y, Bradford BU, Smutney OM, Connor HD, Mason RP, Goyert SM, Peters JM, Gonzalez FJ, Samulski RJ, and Thurman RG. The role of Kupffer cell oxidant production in early ethanol-induced liver disease. Free Radic Biol Med 31: 1544-1549, 2001
193. Winterbourn CC and Metodiewa D. Reactivity of biologically important thiol compounds with superoxide and hydrogen peroxide. Free Radic Biol Med 27: 322-328, 1999
194. Wu RF, Gu Y, Xu YC, Nwariaku FE, and Terada LS. Vascular endothelial growth factor causes translocation of p47phox to membrane ruffles through WAVE1. J Biol Chem 278: 36830-36840, 2003
195. Wu RF, Ma Z, Liu Z, and Terada LS. Nox4-derived H2O2 mediates endoplasmic reticulum signaling through local Ras activation. Mol Cell Biol 30: 3553-3568, 2010
196. Wu RF, Xu YC, Ma Z, Nwariaku FE, Sarosi GA Jr., and Terada LS. Subcellular targeting of oxidants during endothelial cell migration. J Cell Biol 171: 893-904, 2005
197. Yan X, Lin Z, Chen F, Zhao X, Chen H, Ning Y, and Chen YG. Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-beta signaling. J Biol Chem 284: 30097-30104, 2009
198. Yang L and Seki E. Toll-like receptors in liver fibrosis: Cellular crosstalk and mechanisms. Front Physiol 3: 138, 2012
199. Yang L, Bataller R, Dulyx J, Coffman TM, Gines P, Rippe RA, and Brenner DA. Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice. J Hepatol 43: 317-323, 2005
200. Yokohama S, Yoneda M, Haneda M, Okamoto S, Okada M, Aso K, Hasegawa T, Tokusashi Y, Miyokawa N, and Nakamura K. Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis. Hepatology 40: 1222-1225, 2004
201. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, and Fukui H. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 34: 745-750, 2001
202. Zarski JP, Sturm N, Desmorat H, Melin P, Raabe JJ, Bonny C, Sogni P, Pinta A, Rouanet S, Babany G, Cheveau A, and Chevallier M. Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: A randomized study. Liver Int 30: 1049-1058, 2010
203. Zhan SS, Jiang JX, Wu J, Halsted C, Friedman SL, Zern MA, and Torok NJ. Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo. Hepatology 43: 435-443, 2006
204. Zhang DY and Friedman SL. Fibrosis-dependent mechanisms of hepatocarcinogenesis. Hepatology 56: 769-775, 2012
205. Zhang L, Nguyen MV, Lardy B, Jesaitis AJ, Grichine A, Rousset F, Talbot M, Paclet MH, Qian G, and Morel F. New insight into the Nox4 subcellular localization in HEK293 cells: First monoclonal antibodies against Nox4. Biochimie 93: 457-468, 2011
206. Zuo L, Ushio-Fukai M, Ikeda S, Hilenski L, Patrushev N, and Alexander RW. Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: Role in redox signaling and vascular hypertrophy. Arterioscler Thromb Vasc Biol 25: 1824-1830, 2005